Phibro Animal Health Corporation
Price Action
Technical Summary
CONSOLIDATINGPhibro Animal Health Corporation is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 14), showing significant lag compared to the market leaders. Earnings growth of 16% provides fundamental context to the price action. Investors should exercise caution due to high volatility (59% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $31.88 | +3.90% | ABOVE |
| 50 SMA | $36.97 | -10.42% | BELOW |
| 100 SMA | $45.25 | -26.81% | BELOW |
| 150 SMA | $43.73 | -24.26% | BELOW |
| 200 SMA | $43.02 | -23.01% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is PAHC in an uptrend right now?
PAHC has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is PAHC overbought or oversold?
PAHC's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is PAHC outperforming the market?
PAHC has a Relative Strength (RS) Rating of 14 out of 99. PAHC is currently lagging the broader market.
Where is PAHC in its 52-week range?
PAHC is trading at $33.12, which is 55% of its 52-week high ($60.08) and 22% above its 52-week low ($25.58).
How volatile is PAHC?
PAHC has a Beta of 1.09 and 52-week volatility of 59%. It's more volatile than the S&P 500 - expect bigger swings.